Verrica Pharmaceuticals Inc (VRCA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $61.16M
Last updated: Nov 17, 2026 at 10:43 AM ET
Verrica Pharmaceuticals Inc (VRCA) Competitors
The companies most similar to Verrica Pharmaceuticals are Veru (VERU), Pmv Pharmaceuticals (PMVP) and Spero Therapeutics (SPRO). By market cap, Verrica Pharmaceuticals ranks 5th of the 13 companies on this page; Pmv Pharmaceuticals (PMVP) is the largest at $95.93M.
Peer Comparison
VRCA's revenue growth of -51.8% is below the peer median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals (VRCA) | $61.16M | N/A | 3.0x | -189.2% | -496.2% | -51.8% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Pmv Pharmaceuticals Inc (PMVP) | $95.93M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Spero Therapeutics Inc (SPRO) | $58.26M | 11.1x | 1.3x | 15.7% | N/A | -95.6% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vyne Therapeutics Inc (VYNE) | $19.07M | N/A | N/A | 0.0% | N/A | -57.4% | 0.00% |
| RenovoRx Inc (RNXT) | $50.18M | N/A | 16.6x | 0.0% | N/A | 300.8% | 0.00% |
| Genelux Corporation Common Stock (GNLX) | $84.38M | N/A | N/A | 0.0% | N/A | -95.3% | 0.00% |
| Quince Therapeutics, Inc. (QNCX) | $32.27M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vivani Medical Inc. (VANI) | $91.11M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Heron Therapeuti (HRTX) | $59.08M | N/A | 0.4x | -14.5% | -8.4% | -7.8% | 0.00% |
| Serina Therapeutics Inc (SER) | $36.93M | N/A | 288.7x | 0.0% | -109.4% | 154.9% | 0.00% |
| Peer median | $54.22M | 11.1x | 9.0x | 0.0% | -58.9% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Verrica Pharmaceuticals, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
| Pmv Pharmaceuticals Inc (PMVP) | PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53... | PMVP competitors |
| Spero Therapeutics Inc (SPRO) | Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing... | SPRO competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Vyne Therapeutics Inc (VYNE) | VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. | |
| RenovoRx Inc (RNXT) | RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. | RNXT competitors |
| Genelux Corporation Common Stock (GNLX) | Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering... | GNLX competitors |
| Quince Therapeutics, Inc. (QNCX) | Quince Therapeutics, Inc., a biopharmaceutical company, is focused on advancing precision therapies for rare and debilitating diseases. | |
| Vivani Medical Inc. (VANI) | Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery... | VANI competitors |
| Heron Therapeuti (HRTX) | Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. | HRTX competitors |
| Serina Therapeutics Inc (SER) | Serina Therapeutics Inc is a pioneering biotechnology company focused on developing innovative solutions for unmet medical needs in oncology and neurology... | SER competitors |
Frequently Asked Questions About VRCA
Who are Verrica Pharmaceuticals' main competitors?
The companies most similar to Verrica Pharmaceuticals include Veru (VERU), Pmv Pharmaceuticals (PMVP), Spero Therapeutics (SPRO), vTv Therapeutics (VTVT) and Grace Therapeutics (GRCE), listed from the closest match.
Who is Verrica Pharmaceuticals' biggest competitor?
Pmv Pharmaceuticals (PMVP) is the largest of the similar companies at $95.93M; Veru (VERU) is the closest match by business profile, size, sector and industry.
How does VRCA stock compare with its competitors?
VRCA's P/S is 3.0x against a peer median of 9.0x; its net margin is -189.2% against a peer median of 0.0%.
Which of Verrica Pharmaceuticals' competitors pays a higher dividend?
Verrica Pharmaceuticals pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Verrica Pharmaceuticals bigger than its competitors?
No. Verrica Pharmaceuticals is 5th by market cap among the 13 companies on this page; the largest is Pmv Pharmaceuticals (PMVP) at $95.93M.
VRCA pages: Overview, Earnings, Forecast, Financials, Competitors